Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Share Price

Price 2.11p on 11-07-2025 at 18:50:07
Change -0.01p -0.46%
Buy 2.19p
Sell 2.10p
Buy / Sell IMM Shares
Last Trade: Sell 59,986.00 at 2.1118p
Day's Volume: 1,171,634
Last Close: 2.145p
Open: 2.10p
ISIN: GB0033711010
Day's Range 2.10p - 2.18p
52wk Range: 0.85p - 7.26p
Market Capitalisation: £9m
VWAP: 2.129158p
Shares in Issue: 416m

Immupharma (IMM) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 59,986 2.1118p Ordinary
16:17:45 - 11-Jul-25
Buy* 92,800 2.1492p Ordinary
16:00:08 - 11-Jul-25
Buy* 23,255 2.1492p Ordinary
15:50:44 - 11-Jul-25
Sell* 120,000 2.1121p Ordinary
15:41:07 - 11-Jul-25
Sell* 24,235 2.10p SI Trade
14:06:51 - 11-Jul-25
Sell* 7,855 2.11p Automatic Execution
14:06:51 - 11-Jul-25
Sell* 29,018 2.10p Automatic Execution
14:06:51 - 11-Jul-25
Sell* 4,765 2.10p SI Trade
14:06:50 - 11-Jul-25
Sell* 14,149 2.10p SI Trade
14:06:50 - 11-Jul-25
Buy* 4,427 2.169p Ordinary
12:49:26 - 11-Jul-25
See more Immupharma trades

Immupharma (IMM) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Jul 2025 (Fri) 2.10 2.18 2.10 2.145 1,171,634
10th Jul 2025 (Thu) 2.25 2.25 2.11 2.155 683,853
9th Jul 2025 (Wed) 2.11 2.24 2.11 2.155 1,306,835
8th Jul 2025 (Tue) 2.16 2.25 2.10 2.135 2,132,265
7th Jul 2025 (Mon) 2.15 2.18 2.15 2.185 1,618,156
4th Jul 2025 (Fri) 2.16 2.16 2.12 2.17 909,077
3rd Jul 2025 (Thu) 2.10 2.32 2.10 2.25 1,167,245
2nd Jul 2025 (Wed) 2.35 2.35 2.17 2.18 1,072,277
1st Jul 2025 (Tue) 2.38 2.38 2.20 2.22 1,415,552
30th Jun 2025 (Mon) 2.36 2.36 2.27 2.30 1,417,754
27th Jun 2025 (Fri) 2.41 2.41 2.40 2.52 1,571,949
26th Jun 2025 (Thu) 2.31 2.69 2.25 2.525 4,113,721
25th Jun 2025 (Wed) 2.24 2.26 2.21 2.265 1,532,721
24th Jun 2025 (Tue) 2.28 2.33 2.27 2.24 765,195
23rd Jun 2025 (Mon) 2.35 2.35 2.30 2.315 916,627
20th Jun 2025 (Fri) 2.27 2.30 2.27 2.395 1,351,173
19th Jun 2025 (Thu) 2.35 2.50 2.30 2.28 1,102,050
18th Jun 2025 (Wed) 2.35 2.59 2.31 2.42 895,664
17th Jun 2025 (Tue) 2.30 2.40 2.30 2.40 318,622
16th Jun 2025 (Mon) 2.35 2.35 2.30 2.415 943,028
13th Jun 2025 (Fri) 2.50 2.50 2.32 2.43 2,267,595
12th Jun 2025 (Thu) 2.53 2.53 2.42 2.63 1,935,835
See more Immupharma price history

Immupharma (IMM) Regulatory News

Date Source Headline
12th Jun 2025 12:51 pm RNS Result of AGM
27th May 2025 3:13 pm RNS Holding(s) in Company
20th May 2025 7:00 am RNS Notice of AGM
19th May 2025 7:00 am RNS Final Results
1st Apr 2025 7:00 am RNS Warrant Extension, Debt Conversion & Equity Issue
1st Apr 2025 7:00 am RNS Extension of Warrants in Incanthera to 30 Sep 2025
14th Mar 2025 7:00 am RNS-R IMM attending Bio-Europe Spring 17-19 March,Milan
13th Mar 2025 7:00 am RNS ImmuPharma proves unique Mechanism of Action-P140
21st Feb 2025 11:36 am RNS Holding(s) in Company
13th Feb 2025 7:00 am RNS £2.91m fundraising; related party transactions
See more Immupharma regulatory news

Immupharma (IMM) Share News

Immupharma annual loss narrows as focused on clinical assets

19th May 2025 10:37

(Alliance News) - ImmuPharma PLC on Monday said its core anti-infective programme with antifungal and antibacterial candidates is progressing through pre-clinical studies, amid a narrowed loss. Read More

ImmuPharma celebrates "significant milestone" for P140 platform

13th Mar 2025 16:27

(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform. Read More

AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses

13th Mar 2025 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

IN BRIEF: ImmuPharma notes share price surge after novel findings

28th Jan 2025 14:28

ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multiplied nearly five times higher in the last month to 6.03p per share, from 1.21p. The stock surged 94% higher in a single day in early January, to 2.33p, after ImmuPharma reported breakthrough findings in its preclinical research programme focused on P140 and the pathogenesis of autoimmune diseases. Read More

IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings

9th Jan 2025 11:21

ImmuPharma PLC - London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 and the pathogenesis of autoimmune diseases has yielded data that provides novel insights into autoimmune mechanisms. P140, the firms lead programme, is a unique non-immunosuppressive peptide for the treatment of systemic lupus erythematosus and chronic idiopathic demyelinating polyneuropathy. Adds that the findings, which were discovered by its R&D subsidiary ImmuPharma Biotech, pave the way for better diagnostics, identifying patients most likely to respond to P140 therapy and improved patient monitoring. Says the research marks a "significant step towards personalised medicine in SLE and other autoimmune diseases." Details of the data findings are not being released at this time since they form part of the ongoing expansion of the firms intellectual property portfolio. Read More

See more Immupharma news
FTSE 100 Latest
Value8,941.12
Change-34.54

Login to your account

Forgot Password?

Not Registered